Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECORDS: Corticotherapy in Sepsis
NCT04280497Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2020
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of hydrocortisone and fludrocortisone in sepsis (12 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Composite of death or persistent organ dysfunction at 90 days and Persistent organ dysfunction at 3 months. Started Apr 2020; status: recruiting.
02
Drugs
hydrocortisonefludrocortisone
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT04280497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04280497.